Aortic Valve Calcification

DurAVR™ THV EU-EFS

Valvosoft Outcomes Registry for Real-World Evidence

Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study

Colchicine and Inflammation in Aortic Stenosis

ACURATE neo2™ Post Market Clinical Follow up Study

ACURATE Enhance Post Market Study

Identification of Genetic Causes of Calcific Aortic Valve Disease

Valvular Assessment of New Generation Aortic Replacement Devices

VALVOSOFT® Pivotal Study

DurAVR™ THV System: First-In-Human Study

Clinical Investigation for the Foldax Tria Aortic Heart Valve- India

Role of Aortic Valve Composition in Pathophysiology and Diagnosis of Aortic Stenosis

Deploying Novel Imaging Modalities Towards a Three-dimensional (3D) CARDIOvascular PATHology

Biomarkers and Mechanisms of Disease Progression and Outcome of Aortic Stenosis in Humans

SLOW-Slower Progress of caLcificatiOn With Vitamin K2

Evaluation of the Inflammatory Response in Post-operated Aortic Valve Replacement Patients.

Left Ventricular Reverse Remodeling In Aortic Valve Replacement With Single Strip Pericardium Versus Mechanical Valve

REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve SystEm

Prevalence and Significance of Mutations in Genes Encoding NaPi-co-transporters in the Development of CAVD

Vitamin K Supplement for Inhibition of the Progress in Aortic Valve Calcification